STAT+: Pharmalittle: We’re reading about compounders suing the FDA, Biogen turning to telehealth, and more
STAT
OCTOBER 8, 2024
… A trade group representing large compounding pharmacies has sued the U.S. Food and Drug Administration for a “reckless and arbitrary” decision to remove a widely prescribed Eli Lilly drug for combating diabetes and obesity from an official shortages list , STAT tells us.
Let's personalize your content